Gene therapy treatment for AMD in clinical trials

Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]

New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, BeovuĀ®, for the treatment of wet age-related macular degeneration (AMD). BeovuĀ® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

New implant delivers medicine continuously to eye

The current therapy for treating wet macular degeneration involves costly, frequent injections into the eye. Researchers are currently working on a new therapy that involves putting an implant into the eye that would continuously deliver the medication into the eye. Injection therapy only offers temporary help in preserving central vision with wet macular degeneration and […]

Donor Cells Implanted for Macular Degeneration

Researchers at the Riken Institute in Japan completed the first clinical trial involving the transplantation of induced pluripotent stem cells (iPS cells) from donors. Five patients received the donated cells. Artificially grown retinal cells were made from donor iPS cells and were used to treat the patients suffering from wet age-related macular degeneration. The first […]

Breakthrough Macular Degeneration research announced

Researchers at the University of California – Berkeley have found a way to treat eye diseases such as macular degeneration by turning ganglion cells into cells that can sense light. Many degenerative eye diseases are caused by photoreceptors that no longer work correctly. This new technique eliminates the need for photoreceptor cells. Using an inactivated […]

Which medication is best for wet macular degeneration?

Johns Hopkins University School of Medicine researchers studied the ocular as well as systemic effects that three anti-VEGF therapies had on patients. Pegatanib, ranibizumab and bevacizumab were all compared to patients who received no anti-VEGF treatments Researchers evaluated specific studies from databases and focused on 16 randomized controlled trials that had a total of 6347 […]

Revolutionary treatment restores vision

A study that involved a revolutionary treatment using stem cells from the eyes of non-living donors is detailed in STEM CELLS Translational Medicine. Researchers hope that this pioneering treatment may hold the key to finding a cure for blindness that is caused by damage to the cornea. Eight patients with condition known as Limbal stem […]

Gene therapy used to treat AMD

A surgeon at the John Radcliffe Hospital in the UK successfully injected a synthetic gene into a patient’s eye in the hope of stopping the progression of age-related macular degeneration. The patient, Janet Osborne, is the first person to receive the gene therapy in the trial that is being conducted at the John Radcliffe Hospital […]

Oranges reduce AMD risk 60%

Forget an apple a day to keep the doctor away, reach for an orange as a recent study shows that eating an orange a day can reduce your risk of developing late macular degeneration by as much as 60 percent. The flavonoids found in oranges provide a special protection against age-related macular degeneration. Researchers at […]

Eye calcifications raise AMD risk

Researchers at the University of Alabama at Birmingham in collaboration with the Queen’s University Belfast made a breakthrough discovery regarding age-related macular degeneration (AMD). Researchers discovered that calcified nodules in the retina are linked to an increase risk for the progression to advanced AMD. Researchers studied clinical imaging in patients as well as molecular analysis […]